TY - JOUR
T1 - A high performance liquid chromatographic method for the determination of febantel and its major metabolites in lamb plasma
AU - Landuyt, J.
AU - Debackere, M.
AU - Delbeke, F.
AU - McKellar, Quintin
N1 - Medline is the source for the MeSH terms of this document.
PY - 1993/3
Y1 - 1993/3
N2 - A high performance liquid chromatographic (HPLC) method for the determination of the anthelminthic pro-benzimidazole febantel and its major metaboites in lamb plasma has been developed. Samples were extracted after addition of albendazole as internal standard, NHOH and distilled diethyl ether. The extracted phase was dried under a stream of nitrogen redissolved in methanol and chromatographed by HPLC. Detection was by UV absorbance at 292 nm. Recovery from the plasma was 97.2, 97.1, 54.5 and 88.0% for febantel, fenbendazole, oxfendazole and oxfendazole sulphone respectively, and within-day and between-day coefficients of variation were 4.03, 4.69, 3.57 and 5.06% and 4.25, 3.73, 5.12 and 4.12%, respectively, for febantel, fenbendazole, oxfendazole and oxfendazole sulphone. The specificity and sensitivity of this method (limit of detection in plasma 0.025 μg/mL and ≤0.0125 μg/mL for febantel and its metabolites, respectively) were sufficiently high to enable us to characterize the time course of the drug in the plasma after oral administration of therapeutic doses to sheep.
AB - A high performance liquid chromatographic (HPLC) method for the determination of the anthelminthic pro-benzimidazole febantel and its major metaboites in lamb plasma has been developed. Samples were extracted after addition of albendazole as internal standard, NHOH and distilled diethyl ether. The extracted phase was dried under a stream of nitrogen redissolved in methanol and chromatographed by HPLC. Detection was by UV absorbance at 292 nm. Recovery from the plasma was 97.2, 97.1, 54.5 and 88.0% for febantel, fenbendazole, oxfendazole and oxfendazole sulphone respectively, and within-day and between-day coefficients of variation were 4.03, 4.69, 3.57 and 5.06% and 4.25, 3.73, 5.12 and 4.12%, respectively, for febantel, fenbendazole, oxfendazole and oxfendazole sulphone. The specificity and sensitivity of this method (limit of detection in plasma 0.025 μg/mL and ≤0.0125 μg/mL for febantel and its metabolites, respectively) were sufficiently high to enable us to characterize the time course of the drug in the plasma after oral administration of therapeutic doses to sheep.
UR - http://www.scopus.com/inward/record.url?scp=0027300138&partnerID=8YFLogxK
U2 - 10.1002/bmc.1130070206
DO - 10.1002/bmc.1130070206
M3 - Article
AN - SCOPUS:0027300138
SN - 0269-3879
VL - 7
SP - 78
EP - 81
JO - Biomedical Chromatography
JF - Biomedical Chromatography
IS - 2
ER -